Patents by Inventor Amber Howerton

Amber Howerton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reducing risk of contracting clostridium-difficile associated disease
    Patent number: 9862744
    Abstract: A method of treating a patient to reduce risk of developing Clostridium difficile-associated disease or reducing existing Clostridium difficile-associated disease in a mammalian subject involves administering to a mammalian subject an effective amount of a germination-inhibiting compound derived from taurocholate. Novel compounds of this class are also provided.
    Type: Grant
    Filed: July 13, 2015
    Date of Patent: January 9, 2018
    Assignee: THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS
    Inventors: Ernesto Abel-Santos, Amber Howerton
  • Reducing Risk of Contracting Clostridium-Difficile Associated Disease
    Publication number: 20160009753
    Abstract: A method of treating a patient to reduce risk of developing Clostridium difficile-associated disease or reducing existing Clostridium difficile-associated disease in a mammalian subject involves administering to a mammalian subject an effective amount of a germination-inhibiting compound derived from taurocholate. Novel compounds of this class are also provided.
    Type: Application
    Filed: July 13, 2015
    Publication date: January 14, 2016
    Inventors: Ernesto Abel-Santos, Amber Howerton
  • Reducing risk of contracting associated disease
    Patent number: 9079935
    Abstract: A method of treating a patient to reduce risk of developing Clostridium difficile-associated disease or reducing existing Clostridium difficile-associated disease in a mammalian subject involves administering to a mammalian subject an effective amount of a germination-inhibiting compound derived from taurocholate. Novel compounds of this class are also provided.
    Type: Grant
    Filed: August 8, 2013
    Date of Patent: July 14, 2015
    Assignee: The Board of Regents of the Nevada System of Higher Education on Behalf of The University of Nevada, Las Vegas
    Inventors: Ernesto Abel-Santos, Amber Howerton
  • Reducing Risk of Contracting Clostridium-Difficile Associated Disease
    Publication number: 20140045808
    Abstract: A method of treating a patient to reduce risk of developing Clostridium difficile-associated disease or reducing existing Clostridium difficile-associated disease in a mammalian subject involves administering to a mammalian subject an effective amount of a germination-inhibiting compound derived from taurocholate. Novel compounds of this class are also provided.
    Type: Application
    Filed: August 8, 2013
    Publication date: February 13, 2014
    Applicants: of Nevada, Las Vegas
    Inventors: Ernesto Abel-Santos, Amber Howerton
  • Reducing risk of contracting clostridium-difficile associated disease
    Patent number: RE49949
    Abstract: A method of treating a patient to reduce risk of developing Clostridium difficile-associated disease or reducing existing Clostridium difficile-associated disease in a mammalian subject involves administering to a mammalian subject an effective amount of a germination-inhibiting compound derived from taurocholate. Novel compounds of this class are also provided.
    Type: Grant
    Filed: January 9, 2020
    Date of Patent: April 30, 2024
    Assignee: THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS
    Inventors: Ernesto Abel-Santos, Amber Howerton